MedTrace Logo

The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events

NCT06379529 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050

Last updated 2025-05-28

No results posted yet for this study

Summary

A 12 month interventional study of up to 1,050 people with COPD to determine if the NuvoAir virtual-first clinical service leads to fewer moderate and severe COPD exacerbations and cardiac events, reduces healthcare utilization, and lowers the total cost of care compared to a control cohort that receives standard care only.

Conditions

  • COPD Exacerbation
  • COPD
  • Cardio/Pulm: Heart Failure

Interventions

OTHER

NuvoAir clinical service

Patients with COPD receiving usual care plus NuvoAir clinical services.

Sponsors & Collaborators

  • Optum, Inc.

    collaborator INDUSTRY

  • NuvoAir Medical PC

    lead INDUSTRY

Principal Investigators

  • Ken Cohen, MD · Executive Director of Translational Research, OptumCare

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-01-01
Completion
2027-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06379529 on ClinicalTrials.gov